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Abstract 
There has been a continuous strive to develop a portable, low cost, stable and sensitive 
detection system for malaria to meet the demand in the diseased endemic regions, located 
mostly in economically poor countries. Herein, we report a portable FET-based biosensor 
(BioFET) developed by using extended gate field effect transistor (EGFET) with inter 
digitated gold microelectrodes (IDµE) and pseudo reference electrode for the detection of 
malaria biomarker Plasmodium falciparum glutamate dehydrogenase (PfGDH) in serum 
samples. A 90 mer long ssDNA aptamer (NG3) selective for PfGDH was used in the BioFET 
to capture the protein. The intrinsic surface net charge of the captured protein induces gate 
potential shift of the device which could be correlated to the concentration of the captured 
protein. The device could generate a dynamic detection range of 100 fM  10 nM with a limit 
of detection (LOD) of 16.7 pM for PfGDH in buffer samples. The BioFET sensor when 
tested in diluted serum samples offered an LOD of 48.6 pM, which is well within the relevant 
clinical range of the disease. The high selectivity of the sensor for PfGDH was verified by 
testing relevant analogous human and parasitic proteins in the device. Overall, the results 
validated the potential application of the developed BioFET for diagnosis of both 
symptomatic and asymptomatic malaria.  
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1. Introduction 
Malaria is a serious life threatening disease, affecting a large section of the population mostly 
in tropical and subtropical low and middle income countries (Gallup and Sachs, 2001; World 
malaria report, 2016). Usually, malaria is a curable disease if diagnosed and treated promptly
correctly. There are many reliable laboratory based methods available for malaria 
diagnosis. However, these methods are time-consuming, expensive and require skilled 
operators and hence, are not destined to deploy in point of care and remote resource limited 
malaria endemic regions (Tangpukdee et al., 2009). Currently, lateral flow based immuno-
chromatographic tests, commonly known as rapid diagnostic tests (RDTs), are widely used in 
malaria prevalent countries. However, these antibody based RDTs are usually non-
quantitative in nature and their storage stability is impaired in hot and humid environment 
which is a typical climate in  most of the malaria endemic regions (Ranadive et al., 2017). 
Over the last decade there has been a continuous strive to replace antibodies and other labile 
biorecognition elements with stable recognition systems for developing various diagnostic 
and detection devices (Thiviyanathan and Gorenstein., 2012). Among them, nucleic acid 
based aptamers are emerging as efficient and viable alternative to the antibodies. The binding 
affinity of the ssDNA aptamers is usually comparable to the antibodies.  The aptamer can be 
produced economically in a large scale following established chemical protocols. Moreover, 
there is a scope to enhance the selectivity of the DNA aptamers by chemical means (Song et 
al., 2012). There are few reports on developing aptamer-based malaria detection approaches 
(Cheung et al., 2013; Jain et al., 2016, Singh et al. 2018a). These proof-of-concepts are relied 
mostly upon the optical principles, while a few of them exploited electrochemical principles 
such as amperometry, voltammetry (Lee et al., 2012; Miranda et al., 2018) and impedance 
spectroscopy (Singh et al., 2018b). Each of these methods however, has their own merits and 
demerits as discussed in these reports. Our focus however, is to explore a portable detection 
device that complies well with the ASSURED (Affordable, Sensitive, Specific, User-friendly, 
Rapid and robust, Equipment free and Deliverable to end-users) mandate of WHO for 
application of such diagnostic tools in developing and underdeveloped countries (Kunte and 
Kunwar, 2011). Herein, we proposed an extended gate field effect transistor (EGFET) based 
detection of P. falciparum malaria using a selective aptamer as biorecognition element 
against the malaria biomarker Plasmodium falciparum glutamate dehydrogenase (PfGDH).  
The use of field effect transistors (FET) as sensing platform has gained enormous attention in 
diagnosis of various diseases (Estrela & Migliorato, 2007; Estrela et al., 2010; Formisano et 
al., 2016; Aliakbarinodehi et al., 2017). The major motivations for using FETs as biosensing 
platform (BioFETs) are their high sensitivity, rapid response time, small size, and cheap 
fabrication process using integrated circuit technology. The FET provides a non-Faradic 
electrochemical measurement, which is sensitive and simple to monitor the reaction occurring 
between solution and electrode surface, without using any redox probe (Park et al., 2012a). In 
its simplest form, the FET measures variations in the open circuit potential that occur at the 
electrode interface. The EGFET was introduced to further increase the sensitivity and to 
overcome any instability issues that may occur during contact of FETs with biological 
samples (Kaisti, 2017). In the EGFET structure, the gate of the transistor is extended away 
from the semiconductor and immersed in a solution for the measurement process, which 
gives an advantage to modify the surface of the extended gate chip as per the need of various 
sensing applications.  
Malaria is caused by five different Plasmodium species amongst which, the Plasmodium 
falciparum is known to cause the most severe form of malaria (Robert et al., 2005). For 
diagnosis of P. falciparum malaria different molecular biomarkers are available (Jain et al., 
2014). The major stimulus of using PfGDH as the target in the present investigation is its 
multifaceted advantages as a reliable biomarker and detection flexibility in the potentiometric 
transducer platform. Moreover, its human counterpart (HGDH) has not been reported in the 
matured human erythrocytes till date. The PfGDH is structurally, kinetically, and sequentially 
(~77 % amino acid) distinct from the host GDH (Wagner et al., 1998; Werner et al., 2005). 
This cytosolic PfGDH with NADP-specific activity is present in the human serum with good 
detectable amounts during the infection (Acosta et al., 1998; Seol et al., 2017). The PfGDH 
catalytic product of the reaction could be set in -ketoglutarate) using 
glutamate as the substrate which may furnish additional signal on the potentiometric platform 
once it is captured by the biorecognition element on the gate surface. The aptamer was 
immobilized over the FET inter digitated gold microelectrodes (IDµE) through gold-thiol 
chemistry (Scheme 1). A detailed account on the interesting findings is incorporated in this 
manuscript.    
 
 Scheme.1 Fabrication scheme of aptamer based EGFET for detection of PfGDH in blood 
serum. 
 
 
2. Experimental Section 
 
2.1 Materials 
The ssDNA Aptamer library and primers obtained from IDT, USA. The selected thiolated  
NG3 aptamer (see Table 1) synthesized from Sigma-Aldrich, UK for the work. The 
Polyvinylidene fluoride (PVDF) was obtained from Amersham, UK, Syber gold (10,000 X) 
was procured from Invitrogen, USA. The pGEMT easy TA cloning kit received from 
Promega, USA. The starting blocking buffer was obtained from Thermo Fisher. The human 
serum from clotted male whole blood type AB received from Sigma Aldrich. The proteins, 
Plasmodium falciparum lactate dehydrogenase (PfLDH), Plasmodium falciparum Histidine 
rich protein-II (PfHRP-II), Plasmodium falciparum glutamate dehydrogenase (PfGDH) and 
Human glutamate dehydrogenase (HGDH) were cloned, expressed and characterised in our 
lab previously  (Jain et al., 2016; Chakma et al., 2016; Singh et al., 2018a). All other 
chemicals and reagents were of analytical grade and used as received. The composition of all 
buffer used for current work are presented in Table S1, supplementary material. 
 Table 1. Thiolated NG3 aptamer sequences. 
Aptamer  
NG3 SH-(CH2)6-TTT TCA CCT CAT ACG ACT CAC TAT AGC GGA TCC GAG 
CCG GGG TGT TCT GTT GGC GGG GGC GGT GGG CGG GCT GGC TCG 
AAC AAG CTT GC 
 
2.2 Development and characterization of aptamer  
SELEX (Systemic Evolution of Ligand by Exponential enrichment) was performed to 
produce specific ssDNA aptamers against PfGDH as the target antigen from a random 
oligonucleotide library (1014-1015) as reported earlier (Singh et al., 2018a). The sequence 
were flanked with conserved primer binding sites -CAC CTA ATA CGA CTC ACT ATA 
GCG GA-N40- GCA AGC TTG TTC GAG CCA G- of which 40 mer sequence (N40) 
conferred the variation. Briefly total 17 rounds of SELEX cycle were performed out of which 
3 negative cycles against PVDF membrane and 2 negative cycles against control HGDH 
protein were executed to eliminate those aptamer candidates from the pool which have 
affinity for PVDF or HGDH. After the end of 17th cycle of SELEX, the amplified pool was 
cloned into pGEMT vector followed by transformation into E. coli  competent cells. 
The positive clones were confirmed by restriction digestion and sequenced, aligned with 
Clustal X2 software for comparison. The dissociation constants (kd) of 79.16 ± 1.58 nM for 
NG3 aptamer was discerned from surface plasmon resonance spectroscopy (Singh et al., 
2018b) 
 
2.3 Determination of isoelectric point (pI) of recombinant PfGDH 
The isoelectric point of purified recombinant PfGDH was measured by zeta potential study 
using a Zetasizer nano series (Malvern Instruments limited, U.K). The zeta potential of 
PfGDH was measured in 50 mM appropriate buffers covering pH range from 2 to 10 in 
capillary cell (DTS1070- Malvern instruments limited) equipped with gold platted 
Beryllium/Copper electrode. A graph was plotted between the measured zeta potential values 
and the corresponding pH values. The pI of PfGDH was identified from the pH scale at 
which the zeta potential becomes zero. 
 
2.4 Electrode cleaning and sensor fabrication 
Interdigitated gold microelectrodes (IDµE) were deposited over silicon or silicon oxide over 
an area of 0.8 cm × 1.6 cm; the electrodes had fingers of 5 µm × 3200 µm interspaced by 10 
µm (Pui et al., 2013; Arya et al., 2018). The microelectrodes were UV-ozone cleaned for 30 
minutes and then washed with steams of acetone, isopropanol and ethanol for 30 seconds 
each sequentially and followed by washing with ample amounts of mili-Q water (
cm). The sample holding region over the microelectrode was produced by sealing the edges 
with molding tape with holding capacity of 50µl. The fabrication of the biolayer over the 
cleaned gold electrode was performed by following a previously reported method (Jolly et al., 
2016; Singh et al., 2018b). In short, 100 mM solution of 6 mercapto 1 hexanol (MCH) was 
prepared in absolute ethanol, which was further diluted to 1 mM in the binding buffer. The 
cleaned microelectrode surface was then incubated with 50 µl solution of thiolated aptamer: 
MCH in a 1:100 ratio for 12 h in a humidity chamber. Prior to the immobilization over the 
electrode, the aptamer was treated at 90 °C for 5 minutes followed by cooling at 4°C for 10 
min to ensure that the immobilized aptamer is free from any hybridization. Following the 
immobilization procedure, the fabricated aptamer electrode was first cleaned with mili-Q 
water to remove unbound aptamer from the electrode surface and then it was further treated 
with 1mM MCH for 1h to ensure backfilling the free spaces in the microelectrode. The 
electrode was washed with mili-Q water and stem jet dry with nitrogen gas. Before the 
BioFET measurement, aptamer/MCH gold microelectrode was treated with starting blocking 
buffer (Thermo Fisher) for 30 minutes to minimize the probability of non-specific 
interactions over the electrode surface. 
2.5 Atomic force microscopy (AFM) study  
The topological characterization of the fabricated gold microelectrodes was performed with 
AFM in continuous tapping mode by Multimode Nanoscope with IIIa controller (Bruker, 
Germany) in combination with control software (version 6). AFM images were captured 
using 10 nm diameter AFM ContAl-G tips (Budget Sensors®, Bulgaria), and then analyzed 
with WsxM version 5 software. 
2.6 Electrochemical impedance spectroscopy (EIS) study 
The layer by layer fabrication of the aptasensor was characterized by means of Faradic EIS 
measurements in a three-electrode configuration with 2 mm on-chip gold electrodes as 
counter and pseudo reference electrode. The measurements were performed in 10 mM 
potassium phosphate buffer pH 8 with 10 mM (K3Fe(CN)6/K4Fe(CN)6) as redox probe using 
a µAutolab III / FRA2 potentiostat/galvanostat (Metrohm, The Netherlands) at equilibrium 
potential with a 25mV A.C. potential in the frequency range 100 kHz to 100mHz. 
2.7 Procedure for FET measurement 
The BioFET measurement was performed using an n-type CMOS metal oxide field-effect 
transistor (MOSFET), with the gate contact connected to the external gold electrode as 
previously reported (Aliakbarinodehi et al., 2017). The FET measurement was performed 
over IDµE integrated with pseudo reference and working electrode with sample holding 
capacity 50µl. The FET transfer characteristics were measured at a drain-to-source voltage, 
VDS, of 50mV, varying the gate-to-source voltage, VGS, from 0V to 3V. These settings protect 
the device from heating and reduce the risk of false measurements by the FET system. The 
aptamer FET electrode was incubated in FET measurement buffer until a stable signal was 
obtained, followed by incubation of different concentration of PfGDH protein spiked in 
binding buffer or diluted human serum (10 fold) for 30 minutes and washed with 
measurement buffer prior to the measurement. To ensure the interaction between aptamer and 
protein within the Debye length limitation, low ionic strength potassium phosphate buffer 
(PBS) (or diluted serum) was used as measurement buffer (Chan et al., 1980; Stern et al., 
-1 was calculated using equation (1) where r is the relative 
permittivity, o dielectric constant, kB Boltzmann constant, T temperature, e elementary 
charge, NA Avogadro number and I is ionic strength of solution:  
-1 =( r okBT / 2NAe2I)1/2        (1) 
 
3. Results and discussion 
3.1 Characterization of aptasensor.  
The aptamer was co-immobilized with MCH over IDµE through thiol-gold chemistry. The 
topography of the electrode, when examined with AFM (Fig. 1A), shows that the average 
height of the chip increased from ~6.01 ± 1.21 nm to 7.82 ± 2.14 nm following  
immobilization of the aptamer/MCH layer. The surface root mean square roughness (Rrms) of 
the bare electrode increased from 1.77±0.10 nm to 2.20± 0.42 nm following the formation of 
the self-assembled monolayer (SAM). The average distance of aptamer from electrode 
surface (Rrms,average = Rrms of SAM - Rrms of blank) was 0.43 nm, which facilitated the aptamer 
target interaction due to closer distance and thus overcoming the Debye length (as discussed 
in the next section) limitation. The surface modification was further characterized by EIS 
(Fig. 1B), which shows an increase in charge transfer resistance (Rct) value from 245±15 
for bare electrode to 778±43 -immobilization of aptamer/MCH and to 1955±78  
following subsequent blocking with MCH and starting buffer. The reason for the increase in 
Rct value after aptamer immobilization is attributed to the charge repulsion from the electrode 
surface due to negative phosphate backbone of aptamer and further increase in Rct value after 
blocking is ascribed to the accommodation of non-conducting blocker protein in free areas of 
the gold electrode surface. The higher impedance value after surface modification and 
blocking confirmed the successful electrode surface functionalization and blocking.  
Before starting the BioFET detection of PfGDH, the stability of the aptamer modified IDµE 
was checked in FET measurement buffer by applying potentials from 0 to 3 V. A modulated 
drift was observed, which was stabilized after 30 min of incubation (Fig. 1C). This change in 
response can be attributed to buried oxide site in surface assembled monolayer and which 
was stabilized by protonation/deprotonating of this oxide layer through the applied potential 
along the time. 
 
 
Fig. 1. A. Characterization of surface modification with AFM, (i) bare gold chip electrode (ii) 
surface assembled monolayer with MCH/Aptamer/ Au. (B) Faradic EIS characterization of 
sensor fabrication, over IDµE and scanned in 10 mM potassium hexacyano ferrate solution 
prepared in PBS. (C) BioFET stability studies of IDµE in binding buffer from the plot of 
drain current versus time. 
 
3.2 BioFET detection of PfGDH 
The folding of the surface grafted aptamer facilitates its interaction with the target protein 
within the Debye length. A characteristic Debye length of ~ 1.5 nm at 30 °C was calculated 
from equation (1) for FET measurement buffer solution (Calculations presented in 
supplementary material). The small size of the folded aptamer offered freedom to use it in a 
BioFET platform as recognition element to overcome the Debye length limitation, which is 
normally exists when antibodies are used (Chu et al., 2017). The thiolated aptamer (NG3) 
modified IDµE was externally connected to the gate of an n-type MOSFET. When the 
applied gate voltage (with respect to the source contact) is higher than the threshold voltage 
of the transistor, a conducting bridge is formed between drain and source. Under this 
condition when the voltage between drain and source is higher than zero (VDS >0), the flow of 
drain current through the bridge under the influence of dielectric of the gate is initiated. In the 
operation of the extended gate BioFET, any kind of molecular interaction at gate surface 
between aptamer and protein leads to a change in the threshold voltage, seen by a potential 
shift on the drain current, ID, versus gate voltage transfer characteristics (ID vs. VGS). For the 
BioFET measurement of PfGDH protein, the aptamer functionalized microelectrode was 
incubated with target protein spiked in diluted serum and buffer for 30 min. The negative 
phosphate backbone of aptamer and the complementary charged amino acid in protein 
induces complex formation between the target PfGDH and the aptamer (Pethig and Kell, 
1987). The net charge produced on the surface of electrode due to aptamer protein complex 
and change with different concentration of PfGDH protein influence the local surface charge 
present over the aptasensor on the microdigitated gold chip electrode with linear relationship 
to PfGDH protein concentration. Despite the shielding of protein surface charge by counter 
ions, a part of intrinsic protein surface could be detected within electrical double layer 
because the aptamer (NG3)  target (PfGDH) interaction occurred adjacent to the electrode 
surface due to smaller dimension of the aptamer (Goda and Miyahara., 2013). In the (Fig. 2A, 
C) shows typical transfer characteristics of an EGFET, displaying incremental shifts of the 
characteristic towards the positive VGS direction due to the binding of PfGDH protein in 
increasing concentrations, both in binding buffer and diluted serum (10 fold) pH 8. This 
positive shift of gate voltage is consistent with the increase of negative charge on the surface 
due to the folding of the aptamer (charge density closer to the electrode increases) and the 
charge of the protein, which has a pI of 6.6 (Fig. S2, Supplementary material). This pI of 
PfGDH was distantly corroborated with the theatrically calculated isoelectric point (pI~ 7.4) 
of PfGDH (Wagner et al., 1998).    
 
 
Fig. 2. FET response of PfGDH spiked in buffer (A), with calibration curve plot between 
PfGDH concentration (100fM to 10nM) and shift in VGS (B). FET response of PfGDH spiked 
in serum (C), with calibration curve plot concentration versus VGS shift (D). 
 
The number of bound protein (N) having an effective electric charge per molecule (q) 
produce a Q = Nq within the Debye length. This contributes to 
the direct proportional relationship between change in gate voltage verses concentration of 
Pf VGS = Q/C = Nq/C) where C is the electric double layer capacitance 
(Goda and Miyahara, 2012). The calibration curves were generated by plotting varying 
concentrations of spiked PfGDH in buffer or serum against the VGS shift at constant 1.4 µA 
drain current (Fig. 2B, D). The calibration plots for PfGDH spiked in serum showed higher 
sensitivity, which was attributed to tertiary structure stabilization of aptamer and protein with 
physiological moieties present in serum (i.e. NADP co-factor for PfGDH, glutamate, proteins 
and salt) (Park et al., 2012b). The linear detection range of 100 fM 10 nM for PfGDH spiked 
in buffer and diluted serum covered the PfGDH detection range (2 nM to 16 nM) discerned 
for the  immune chromatographic dipstick based detection for malaria (Li et al., 2005). The 
limits of PfGDH detection (LOD= 3×sd of blank/ slope of calibration curve) discerned from 
the corresponding calibration plots were 16.7 pM and 48.6 pM in buffer and diluted serum, 
respectively. The sensitivities of the aptasensor were calculated from the calibration plots 
(Fig. 2B, D) and found to be 0.0084 mV/log ([PfGDH]pM in buffer solution (R2 = 0.99) and  
0.0043 mV/ log ([PfGDH] pM) in diluted serum (R2 = 0.98). A minor reduction in sensitivity 
and increase LOD values in serum medium have been attributed to the complex nature of the 
chemical environment in serum samples.  The specificity of the developed aptasensor 
analyzed with 10 nM of each of the analogous human proteins (HGDH, HSA) and malaria 
proteins (PfLDH, PfHRP-II) spiked in buffer, showed much weaker sensing VGS) as 
compared to the target (PfGDH) protein (Fig. 3A, B). The results confirmed the potential use 
of the developed aptasensor for clinical diagnosis of malaria.  
 
 
Fig. 3. (A) Plot of drain current versus gate voltage for the target (PfGDH) and different 
potential interfering proteins. The analysis was performed in buffer at 10nM concentration 
with 30 min time of incubation, shift in gate voltage observed at 1.4 µA drain current. (B) 
Specificity of NG3 aptasensor with analogous spiked protein. 
 
4. Conclusions 
Herein, we report a novel FET based malaria detection device targeting PfGDH antigen in the 
blood serum. The device, which utilized a selective PfGDH  aptamer immobilizing 
chemically over extended interdigitated micro gold electrode, offered a very high sensitivity 
with a detection limit down to a Pico molar level (48.6pM)  in blood serum. This BioFET 
aptasensor offered a wider detection range (100 fM to 10 nM) than the previously reported 
immune chromatographic dipstick (2 - 16 nM) based methods (Li et al., 2005). The wide 
detection range and low LOD will make this BioFET highly useful for monitoring malaria 
treatment response with progressively decrease in parasitic load as well as for monitoring 
non-symptomatic forms of malaria. This miniaturized BioFET (size ~2700 m2 ) over IDµE 
with label free detection capability through non-Faradic measurement principles detects the 
malaria marker antigen through direct readout of intrinsic charge of the capture target 
molecule making the measurement easy and swift. This EGFET based portable aptasensor 
has therefore, high potential to provide fast, simple, and low-cost detection platform for 
diagnosis of malaria in low resource setting malaria endemic regions.    
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